ETLEVA BEJKO M.D.
NPI 1164804431
Internal Medicine - Rheumatology in Vista, CA

Active since June 23, 2015PECOS EnrolledAccepts Medicare Assignment
96.79/100
CMS Quality Rating
2023 W VISTA WAY STE H, VISTA, CA 92083(760) 724-5800 Get Directions Write a Review

NPPES record last updated: February 7, 2023. Verified against the NPPES registry weekly; last sync: August 23, 2026.

Record update history: Feb 7, 2023, Feb 16, 2021, Jul 23, 2020 (3 updates tracked since 2020).

About Etleva Bejko M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

ETLEVA BEJKO M.D. (NPI 1164804431) is an individual rheumatology provider in Vista, California, licensed in California (A169155) and active in the NPI registry since June 2015. She is enrolled in Medicare PECOS and is a graduate of Clvlnd Clinic Lerner College Of Med Of Case Wstn Rsv University (2020).

NPPES Registry Identity

NPI1164804431
Entity TypeIndividualFemale
Primary Taxonomy207RR0500X
Provider Legal NameETLEVA BEJKOCredential: M.D.
Location Address2023 W VISTA WAY STE HVista, CA 92083-6030
Mailing Address2023 W Vista Way Ste HVista, CA 92083-6030 · (216) 861-6200
Sole ProprietorNo
Medical School CMSClvlnd Clinic Lerner College Of Med Of Case Wstn Rsv UniversityGraduated 2020
Enumeration DateJune 23, 2015
Last NPPES UpdateFebruary 7, 20233 updates tracked since enumeration
NPPES CertifiedFebruary 24, 2021
NPI 1164804431 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyInternal Medicine · RheumatologyAllopathic & Osteopathic Physicians
Taxonomy Code207RR0500X
License Licensed in CA · A169155
Definition
An internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases.
2023 W VISTA WAY STE H, Vista, CA 92083

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Etleva Bejko M.d. is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID7810311883
PECOS Enrollment IDI20200723000701
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 19

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) J0717
Certolizumab pegol is a medication injected under a doctor's supervision. It's used to treat certain inflammatory conditions like rheumatoid arthritis. The injection helps reduce symptoms like pain and swelling. Note that this drug isn't for self-administration.
75,600 services24 patients
Injection, tocilizumab, 1 mg J3262
Tocilizumab is a medication administered via injection. It's used to treat certain conditions like rheumatoid arthritis by reducing inflammation in the body. It works by blocking a substance in the body that leads to inflammation.
35,000 services16 patients
Injection, romosozumab-aqqg, 1 mg J3111
Romosozumab-aqqg is a medication given by injection to treat osteoporosis in patients at high risk for fractures. It works by increasing bone mass and strength, reducing the risk of fractures.
25,620 services24 patients
Injection, denosumab, 1 mg J0897
Denosumab is a medication given via injection to strengthen your bones. It works by slowing down the cells that break down bone, improving bone density and reducing the risk of fractures. It's often used for osteoporosis treatment.
8,580 services92 patients
Injection, infliximab, excludes biosimilar, 10 mg J1745
Infliximab is a medication given via injection to treat certain autoimmune conditions. It works by blocking the action of a substance in your body that causes inflammation. Each dose is based on your medical condition and response to treatment.
2,780 services13 patients
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301
Triamcinolone acetonide is a medication used to reduce inflammation in the body. It's given as a 10 mg injection for conditions like allergies, arthritis, or skin problems. The injection helps to decrease swelling, redness, and itching.
963 services87 patients

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 92083 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$140.22 typical visit price
range $62.10 – $184.71
Typical copayment $35.05 (range $15.52 – $46.17)
Most-billed visit code 99204
Established Patient
$108.42 typical visit price
range $20.62 – $151.42
Typical copayment $27.10 (range $5.15 – $37.85)
Most-billed visit code 99214
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

96.79/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Individually scored
Quality94.17
Promoting Interoperability100
Improvement Activities40

Reported Quality Measures

Advance Care Plan
100%580 patients5/55-star benchmark: 100%
Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
Lower rates are better for this measure.
0%63 patients
Falls: Screening for Future Fall Risk
99%564 patients4/55-star benchmark: 100%
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
94%989 patients4/55-star benchmark: 100%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Patients combinedPopulations: 56% · 805 patients
Patients screened: 56% · 805 patients
100%24 patients5/55-star benchmark: 100%
Provide Patients Electronic Access to Their Health Information
94%581 patients4/55-star benchmark: 100%
Screening for Osteoporosis for Women Aged 65-85 Years of Age
76%172 patients4/55-star benchmark: 98%
Use of High-Risk Medications in Older Adults
Lower rates are better for this measure.
Patients appropriateDiagnosis: 1% · 586 patients
Patients totalRate: 4% · 586 patients
3%586 patients4/55-star benchmark: 100%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Etleva Bejko's NPI number?

The NPI number for Etleva Bejko is 1164804431. It was assigned to this individual provider in the NPPES registry on June 23, 2015.

Where is Etleva Bejko located?

Etleva Bejko practices at 2023 W Vista Way Ste H, Vista, CA 92083. The listed phone number is (760) 724-5800.

What is Etleva Bejko's specialty?

The primary specialty registered for this NPI is Internal Medicine, specializing in Rheumatology, with taxonomy code 207RR0500X.

Is Etleva Bejko enrolled in Medicare?

Yes. Etleva Bejko is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

When was this NPI record last updated?

The NPPES record for Etleva Bejko was last updated on February 7, 2023. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 3 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.